Filing Details
- Accession Number:
- 0001225208-21-013850
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-12 18:08:08
- Reporting Period:
- 2021-11-11
- Accepted Time:
- 2021-11-12 18:08:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 78003 | Pfizer Inc | PFE | Pharmaceutical Preparations (2834) | 135315170 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1551792 | D John Young | Pfizer Inc.-Corp. Secretary 235 East 42Nd St. New York NY 10017 | Group President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-11-11 | 2,800 | $50.16 | 459,904 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-11-11 | 3,200 | $50.09 | 456,704 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-11-11 | 4,200 | $50.03 | 452,504 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-11-11 | 6,200 | $50.06 | 446,304 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-11-11 | 9,100 | $50.14 | 437,204 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-11-11 | 9,500 | $50.15 | 427,704 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-11-11 | 9,818 | $50.07 | 417,886 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-11-11 | 11,700 | $50.10 | 406,186 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-11-11 | 15,500 | $50.12 | 390,686 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-11-11 | 30,200 | $50.02 | 360,486 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-11-11 | 47,782 | $50.01 | 312,704 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 2,550 | Indirect | By Rule 16b-3 Plan |
| Common Stock | 1,621 | Indirect | By Trustee under the Pfizer Share Ownership Plan |
Billionaire Hedge Funds
